Cost for QD employees to rent an apartment in Chico, CA. $1,200/month. Please turn off your ad blocker in Quality Digest
Our landlords thank you.
Quality Digest
Published: Wednesday, October 26, 2005 - 22:00 GSK is expanding its Relenza manufacturing capabilities and has contracted with several countries, including the United States, to provide antiviral treatments. The company is also working to develop an avian flu vaccine, and has clinical trials with the H5N1 strain planned for 2006. “These treatments and vaccines are important to address the possible public health concerns arising from an avian flu outbreak,” says Billy Tauzin, president and CEO of the PhRMA. “PhRMA member-companies also are working with U.S. and foreign governments to monitor bird-flu developments, an important step in addressing the health threat. We will continue to be vigilant and responsive to the needs of governments and the public as we work to avoid the spread of avian influenza.” For more information, visit www.phrma.org. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.Pharmaceutical Companies Preparing for Avian Flu Outbreak
The Pharmaceutical Research and Manufacturers of America reports that PhRMA member-companies are helping world governments prepare for the possibility of an avian flu pandemic.An important line of defense in the event of an outbreak will be antiviral drugs such as Tamiflu, a Roche product, and Relenza, a GlaxoSmithKline product. Roche and GSK are working with the World Health Organization to establish rapid-response stockpiles to slow or halt an influenza pandemic, and Roche has received and will fill stockpile orders from around 40 nations. The U.S. government currently has enough Tamiflu for 2.3 million Americans.
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
Quality Digest
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.